Pharmacokinetics and pharmacodynamics of ticagrelor +/- enoxaparin sodium in volunteers

Trial Profile

Pharmacokinetics and pharmacodynamics of ticagrelor +/- enoxaparin sodium in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Mar 2013

At a glance

  • Drugs Ticagrelor (Primary) ; Enoxaparin sodium
  • Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Deep vein thrombosis; Embolism; Myocardial infarction; Peripheral arterial disorders; Small cell lung cancer; Thromboembolism
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top